NEW YORK(GenomeWeb) – Global Enterprises Group today said that it has reached a deal to acquire a majority stake in molecular diagnostics and therapeutics firm Predictive Therapeutics for an undisclosed amount. 

The deal is anticipated to be completed in 10 days, after which changes to Predictive's management and board will be announced, Global said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.